AUTHOR=Cheung Stephanie G. , Goldenthal Ariel R. , Uhlemann Anne-Catrin , Mann J. John , Miller Jeffrey M. , Sublette M. Elizabeth 

TITLE=Systematic Review of Gut Microbiota and Major Depression

JOURNAL=Frontiers in Psychiatry

VOLUME=10

YEAR=2019

URL=https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2019.00034

DOI=10.3389/fpsyt.2019.00034

ISSN=1664-0640

ABSTRACT=<p><bold>Background:</bold> Recently discovered relationships between the gastrointestinal microbiome and the brain have implications for psychiatric disorders, including major depressive disorder (MDD). Bacterial transplantation from MDD patients to rodents produces depression-like behaviors. In humans, case-control studies have examined the gut microbiome in healthy and affected individuals. We systematically reviewed existing studies comparing gut microbial composition in MDD and healthy volunteers.</p><p><bold>Methods:</bold> A PubMed literature search combined the terms “depression,” “depressive disorder,” “stool,” “fecal,” “gut,” and “microbiome” to identify human case-control studies that investigated relationships between MDD and microbiota quantified from stool. We evaluated the resulting studies, focusing on bacterial taxa that were different between MDD and healthy controls.</p><p><bold>Results:</bold> Six eligible studies were found in which 50 taxa exhibited differences (<italic>p</italic> &lt; 0.05) between patients with MDD and controls. Patient characteristics and methodologies varied widely between studies. Five phyla—<italic>Bacteroidetes, Firmicutes, Actinobacteria, Fusobacteria</italic>, and <italic>Protobacteria</italic>—were represented; however, divergent results occurred across studies for all phyla. The largest number of differentiating taxa were within phylum <italic>Firmicutes</italic>, in which nine families and 12 genera differentiated the diagnostic groups. The majority of these families and genera were found to be statistically different between the two groups in two identified studies. Family <italic>Lachnospiraceae</italic> differentiated the diagnostic groups in four studies (with an even split in directionality). Across all five phyla, nine genera were higher in MDD (<italic>Anaerostipes, Blautia, Clostridium, Klebsiella, Lachnospiraceae incertae sedis, Parabacteroides, Parasutterella, Phascolarctobacterium</italic>, and <italic>Streptococcus</italic>), six were lower (<italic>Bifidobacterium, Dialister, Escherichia/Shigella, Faecalibacterium</italic>, and <italic>Ruminococcus</italic>), and six were divergent (<italic>Alistipes, Bacteroides, Megamonas, Oscillibacter, Prevotella</italic>, and <italic>Roseburia</italic>). We highlight mechanisms and products of bacterial metabolism as they may relate to the etiology of depression.</p><p><bold>Conclusions:</bold> No consensus has emerged from existing human studies of depression and gut microbiome concerning which bacterial taxa are most relevant to depression. This may in part be due to differences in study design. Given that bacterial functions are conserved across taxonomic groups, we propose that studying microbial functioning may be more productive than a purely taxonomic approach to understanding the gut microbiome in depression.</p>